Title: Understanding CardioMetabolic Risk – A Silent Threat We Can’t Ignore
The rise in cardiovascular disease (CVD), obesity, and type 2 diabetes (DM2) is one of the most pressing health concerns of our time. CVD remains the leading cause of death for both men and women in the United States. Alarmingly, obesity and insulin resistance—precursors to DM2—significantly increase the risk of developing CVD. Yet, these conditions are largely preventable with early detection and lifestyle changes.
So, how can we spot the danger before it's too late?
What is CardioMetabolic Risk?
Cardiometabolic risk refers to a cluster of modifiable risk factors and biological markers that signal an increased likelihood of developing CVD and type 2 diabetes. According to the National Cholesterol Education Program (NCEP), these include:
- Hormonal imbalances associated with weight gain
- High blood pressure (hypertension)
- Abdominal obesity
- Unhealthy cholesterol levels (low HDL, high LDL, high triglycerides)
- Inflammation and blood clotting tendencies
- Insulin resistance or glucose intolerance
These risk factors form the foundation of what is commonly known as metabolic syndrome, a major driver of heart disease and diabetes.
A Simple and Effective Way to Test – From Home
Thanks to advanced dried blood spot testing, identifying cardiometabolic risk is now easier than ever:
- A simple finger prick provides enough blood
- Sample collection is quick, convenient, and can be done at home
- No need for a phlebotomist or clinic visit
- Samples can be mailed and are stable at room temperature
- Dried samples pose minimal infection risk
- Results are comparable in accuracy to traditional lab-based tests
See the Cardio Metabolic Test
Key Biomarkers in the CardioMetabolic Profile
Let’s take a closer look at the biomarkers used to assess cardiometabolic risk and what they tell us about your health:
High Sensitivity C-Reactive Protein (hs-CRP)
- Indicates low-grade inflammation and is a strong predictor of heart attack, stroke, and DM2
- Elevated in overweight, insulin-resistant, or diabetic individuals
- Lowered by lifestyle changes (exercise, weight loss, quitting smoking) and medications (aspirin, statins)
- Levels <3.0 mg/L are normal; 3.1–10 mg/L suggests chronic inflammation; >10 mg/L may indicate infection
Fasting Insulin
- Reflects how the body responds to insulin
- High levels signal insulin resistance, often present even if blood sugar appears normal
- Optimal range: 2–6 μIU/mL
Hemoglobin A1c (HbA1c)
- Shows average blood sugar levels over the past 3 months
- Helps detect prediabetes and diabetes
- <5.7% = normal, 5.7–6.4% = prediabetes, ≥6.5% = diabetes
- Target for diabetics: <7% to reduce complications
- Levels above 6% are linked to higher CVD risk
Fasting Triglycerides
- High levels (>150 mg/dL) point to atherogenic dyslipidemia, common in DM2 and obesity
- Ideal: <100 mg/dL for optimal heart health
- Elevated levels increase the risk of heart disease and stroke
Cholesterol Markers (Total, LDL, HDL, VLDL)
- High LDL and VLDL and low HDL cholesterol are major CVD risk factors
- LDL/HDL ratio is a key predictor: the lower, the better
- HDL is protective; low HDL is part of metabolic syndrome
-
Optimal levels:
- Total cholesterol: <200 mg/dL
- LDL: <100 mg/dL (or <70 mg/dL for high-risk individuals)
- HDL: >40 mg/dL
- VLDL: <30 mg/dL
Why This Matters
Chronic conditions like heart disease and diabetes don't appear overnight—they develop silently over time. Identifying cardiometabolic risk early offers a critical opportunity to take action through:
- Improved nutrition
- Regular physical activity
- Stress management
- Medical interventions, if necessary
Testing your cardiometabolic profile can empower you to make informed health decisions and prevent life-threatening conditions before they take hold.
Final Thoughts
We are at a turning point where prevention must take precedence over treatment. The CardioMetabolic Profile offers a simple, science-backed way to uncover hidden risks and take control of your health—starting now, right from your own home.
Don't wait for symptoms. Test early. Act now. Live better.
Related Tests
CardioMetabolic Profile Tests:
Insulin, hsCRP, HbA1c, TG, CH, HDL, LDL, VLDL (blood spot) Allows early detection of major indicators associated with metabolic/insulin resistance syndrome. Used as a screening profile this can help clinicians make the most appropriate treatment recommendations to reduce the overall risk of type 2 diabetes and CVD. Regular testing can also be used for risk assessment and monitoring. Screening, along with clinical assessment, can be of reliable predictive value for determining overall cardiometabolic risk.